There is no question that our nation’s health care system requires substantial reform. The status quo of soaring health care costs, struggling families, and health care provider shortages across Maine and the nation is unacceptable. Senator Collins frequently works with her colleagues on both sides of the aisle to address these and other important issues facing our nation such as improved mental health care, drug treatment programs, supporting America’s caregivers, and nutrition programs.
As a native to northern Maine, Senator Collins understands the specific challenges that rural communities face for medical care. Throughout her time in the Senate, Senator Collins has consistently supported programs to expand access to and improve the health care system, particularly for citizens living in rural areas.
As a freshman legislator, Senator Collins founded the Senate Diabetes Caucus and has since led the effort to more than triple federal funding for diabetes research.
WASHINGTON, D.C. – U.S. Senators Susan Collins and Angus King announced today that the National Institute of General Medical Sciences is awarding a total of $964,714 to The Jackson Laboratory of Bar Harbor and RockStep Solutions of Portland.
Washington, D.C. — U.S. Senators Susan Collins (R-ME) and Ben Cardin (D-MD) introduced a Senate resolution celebrating "National Direct Support Professionals Recognition Week.” The resolution recognizes the hard work of direct support professionals during the week of September 12th.
Washington, D.C. – U.S. Senator Susan Collins received the National Distinguished Advocacy Award today, the most prestigious honor bestowed by the American Cancer Society Cancer Action Network (ACS CAN) in recognition of her dedication to increased cancer research funding, removing barriers to colorectal cancer screening and improved patient quality of life.
ACS CAN, the advocacy affiliate of the American Cancer Society, presents the annual award to select lawmakers who demonstrate relentless leadership in the area of cancer-related public policy advocacy.
Washington, D.C. — U.S. Senators Susan Collins and Angus King today announced that the Office on Violence Against Women (OVW) has awarded a total of $1,180,000 in grant funding to two Maine organizations to implement programs that support victims of domestic violence, sexual assault, and stalking. Of that funding, $500,000 will be awarded to the Maine Coalition Against Sexual Assault (MECASA) in Augusta and $680,000 will be awarded to the Maine Coalition to End Domestic Violence (MCEDV), also located in Augusta.
WASHINGTON, D.C. – U.S. Senators Susan Collins and Angus King today announced that the U.S. Department of Health and Human Services (HHS) has awarded $200,000 to Cary Medical Center in Caribou as part of its Small Health Care Provider Quality Improvement Program.
Washington, D.C.—Following the strong advocacy byU.S. Senator Susan Collins, the Chairman of the Transportation, Housing, and Urban Development (THUD) Appropriations Subcommittee, the U.S.
WASHINGTON, D.C. – U.S. Senators Susan Collins and Angus King today announced that the Office of National Drug Control Policy (ONDCP) has awarded a total of $2,250,000 in grant funding to several Maine health coalitions to prevent youth substance abuse and foster drug-free communities in Maine. Of that funding, $375,000 will be allocated for three new grant awards while the remaining funding will be allocated to seven projects in the state that have previously received funding from ONDCP.
On August 18, Chris Stover of Windham was enjoying a picnic lunch with his family at Sebago Lake State Park when he was stung by a bee. With a potentially fatal allergy to such stings, he fell to the ground and began to lose consciousness.
WASHINGTON, D.C. – U.S. Senators Susan Collins and Angus King today announced that two agencies within the U.S. Department of Health and Human Services (HHS) have awarded grant funding totaling $605,230 to the State of Maine to help fight the heroin and opioid abuse epidemic. Maine will receive $371,616 from the Substance Abuse and Mental Health Services Administration (SAMHSA) and $233,614 from the Centers for Disease Control and Prevention (CDC) to strengthen drug abuse prevention efforts and better track fatal and nonfatal opioid-involved overdoses in Maine.
WASHINGTON, D.C.— U.S. Senator Susan Collins, the Chairman of the Senate Aging Committee, released a statement following reports that Mylan would increase patient rebates for EpiPen®:
WASHINGTON, D.C. – U.S.
In a 24-hour period in June, six people overdosed on opioids in Sanford, one of whom died as a result. In Monmouth, three people overdosed on heroin in one week. And in April, two people died from overdoses in just two days in Biddeford.
Washington, D.C.—U.S. Senators Susan Collins and Claire McCaskill, the Chairman and Ranking Member of the Senate Special Committee on Aging, sent a letter to AstraZeneca seeking more information on the company’s position that generic competitors to Crestor® should be delayed from entering the market.
Washington, D.C.—U.S. Senators Susan Collins, the Chairman of the Transportation, Housing, and Urban Development (THUD) Appropriations Subcommittee, and Angus King announced today that the City of Portland will be awarded $1,568,592 in Lead Based Paint Hazard Control grant program funding and $246,275 in Healthy Homes Supplemental funding. The city will use the funding to help address lead hazards in 80 housing units, providing safer homes for low and very low-income families with children.
Washington, D.C.—With overwhelming bipartisan support, the U.S. Senate passed a comprehensive, evidence-based response to combat the heroin and opioid epidemic by a vote of 92-2. The Comprehensive Addiction and Recovery Act, or CARA, is cosponsored by U.S. Senator Susan Collins, a member of the Senate Health, Education, Labor, and Pensions Committee. The CARA Conference Report contains two amendments authored by Senator Collins, as well as a number of provisions for which she advocated.
WASHINGTON, D.C.—The U.S. Senate passed the Comprehensive Addiction and Recovery Act, or CARA, Conference Report, cosponsored by U.S. Senator Susan Collins, this afternoon by a vote of 92 to 2. Among many other provisions, this bipartisan legislation will allow nurse practitioners and physician assistants who meet certain criteria to dispense buprenorphine for opioid addiction treatment for the first time.
WASHINGTON, D.C. – U.S. Senators Susan Collins and Angus King announced today that the Maine Department of Health and Human Services (DHHS) will receive $176,049 in federal funding from the U.S. Centers for Disease Control and Prevention (CDC) to bolster public health system preparedness and response capabilities to protect Americans from the Zika virus.
Washington, D.C.—U.S. Senator Susan Collins, a senior member of the Senate Appropriations Committee, announced today that the Committee has approved the fiscal year 2017 Labor, Health and Human Services, and Education and Related Agencies (Labor-HHS) Appropriations Bill with $261 million for the Department of Health and Human Services’ opioid abuse initiatives, a 93 percent increase. The legislation was approved by a vote of 29 to 1 and will now be considered by the full Senate.
Washington, D.C.—U.S. Senator Susan Collins, the Co-Chair of the Congressional Task Force on Alzheimer’s Disease and a senior member of the Senate Appropriations Committee, announced today that the Committee approved $1.391 billion for Alzheimer’s research at the National Institutes of Health, an increase of $400 million.
Washington, D.C.–A companion bill to the Stop, Observe, Ask and Respond (SOAR) to Health and Wellness Act, which was introduced in the Senate by Senators Susan Collins (R-ME) and Heidi Heitkamp (D-ND), was introduced in the House yesterday by Congressman Steve Cohen (D-TN), Congressman Adam Kinzinger (R-IL), Congressman Tony Cárdenas (D-CA) and Congresswoman Ann Wagner (R-MO). This bipartisan legislation would provide health care professionals at all levels training on how to identify and appropriately treat human trafficking victims.
WASHINGTON, D.C.—As part of a multifaceted approach to address our nation’s opioid abuse and heroin public health crisis, U.S. Senators Susan Collins (R-Maine) and Claire McCaskill (D-Missouri), the Chairman and Ranking Member of the Senate Aging Committee, have written to five companies regarding their efforts to preserve the accessibility of the opioid reversal drug naloxone.
Washington, D.C.—U.S. Senator Susan Collins joined a bipartisan group of 22 Senators in writing to Sylvia Burwell, Secretary of the Department of Health and Human Services (DHHS), to urge DHHS to allow for greater access to medication assisted treatment (MAT) in the Department’s proposed rule on the topic published on March 30, 2016.
Washington, D.C.—U.S. Senator Susan Collins, a senior member of the Senate Appropriations Commerce, Justice, Science, and Related Agencies Subcommittee, announced today that the Senate Appropriations Committee has approved $132 million to combat the heroin and opioid abuse crisis. The legislation was unanimously approved by the Committee and will now be considered by the full Senate.
In 1947, a virus was discovered in the Zika Forest of Uganda. For nearly all of the next 70 years, that now infamous infection was confined to a narrow band along the Equator in Africa and Asia, and the mosquito-borne virus was believed to cause little more than mild fever symptoms that passed in about one week.
Washington, D.C.—U.S. Senators Susan Collins and Angus King announced that the Mount Desert Island Biological Laboratory has been awarded $249,000 by the National Institute of Neurological Disorders and Stroke. The grant will allow researchers to study a possible cause of chemotherapy-induced peripheral neuropathy (CIPN).
Washington, D.C.—Following strong advocacy and leadership from U.S. Senator Susan Collins, the Chairman of the Transportation, Housing, and Urban Development (THUD) Appropriations Subcommittee, the Senate passed a bipartisan amendment to the THUD bill that would provide $1.1 billion in emergency funding to address the Zika threat, including $361 million for the Centers for Disease Control and Prevention (CDC) and $200 million for the National Institutes of Health.